Neko Health has announced that it has raised a staggering $700 million in funding to further develop its revolutionary AI-driven body scan technology, starting with the establishment of a clinic in New York.
The company's preventive screening service combines medical imaging, blood tests, proprietary sensors, and clinician review. This innovative approach allows for a comprehensive assessment of an individual's health, enabling early detection of potential issues before they become major problems.
Neko Health's Series C round was led by Lightspeed Venture Partners and co-led by O.G. Venture Partners. Existing investors have also participated in the funding round, which demonstrates significant interest in the company's technology. This investment is expected to fuel further development and expansion of Neko Health's AI body scan services, making it an attractive option for individuals seeking improved health monitoring and preventive care.